These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10404854

  • 1. Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.
    Radevski IV, Valtchanova SP, Candy GP, Tshele EF, Sareli P.
    Am J Cardiol; 1999 Jul 01; 84(1):70-5. PubMed ID: 10404854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990 Jul 01; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R, Widmann L, Uberbacher HJ, Hörrmann M, Machwirth M, Stienen U.
    Eur J Clin Pharmacol; 1990 Jul 01; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [Abstract] [Full Text] [Related]

  • 5. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 01; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of acebutolol and hydrochlorothiazide in essential hypertension.
    Lewis JE.
    Am Heart J; 1985 May 01; 109(5 Pt 2):1168-74. PubMed ID: 2859781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
    Dupont AG, Schoors DF, Venuti RP.
    Eur J Clin Pharmacol; 1990 May 01; 38 Suppl 2():S153-7. PubMed ID: 1974507
    [Abstract] [Full Text] [Related]

  • 11. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG, Baxter GA, Young PH.
    J Cardiovasc Pharmacol; 1991 May 01; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [Abstract] [Full Text] [Related]

  • 12. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.
    Drugs R D; 2011 May 01; 11(2):171-90. PubMed ID: 21679007
    [Abstract] [Full Text] [Related]

  • 13. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, INVEST Investigators.
    JAMA; 2003 Dec 03; 290(21):2805-16. PubMed ID: 14657064
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S, Aurup P, Snavely D, Goldberg A.
    Am J Cardiol; 2001 Mar 15; 87(6):721-6. PubMed ID: 11249890
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension.
    Radevski IV, Valtchanova ZP, Candy GP, Hlatswayo MN, Sareli P.
    J Clin Pharmacol; 2000 Jul 15; 40(7):713-21. PubMed ID: 10883412
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 Jul 15; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 17. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D, Tammaro P, del Viscovo L, Lama D, Galzerano A, Breglio R, Tuccillo B, Paolisso G, Capogrosso P.
    Am J Hypertens; 2005 Dec 15; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [Abstract] [Full Text] [Related]

  • 18. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
    Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL.
    Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437
    [Abstract] [Full Text] [Related]

  • 19. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V, Gottdiener JS, Narayan P, Cushman WG, Zachariah PK, Gottdiener PS, Chase GA.
    J Am Coll Cardiol; 1997 Dec 01; 30(7):1802-8. PubMed ID: 9385910
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    Clin Ther; 1996 Dec 01; 18(3):411-28. PubMed ID: 8829017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.